| Literature DB >> 32723292 |
Taohong Chen1,2, Leli Wang1,2, Qinxin Li1,2, Yingjie Long1,2, Yuming Lin1,2, Jie Yin1,2, Yan Zeng1,2, Le Huang1,2, Tingyu Yao1,2, Muhammad Nazeer Abbasi3, Huansheng Yang1,2, Qiye Wang1,2, Congjia Tang1,2, Tahir Ali Khan1, Qiuyue Liu4, Jia Yin5,6, Qiang Tu7, Yulong Yin1,2,8.
Abstract
BACKGROUND: Probiotics are being considered as valuable microorganisms related to human health. Hu sheep is referred as one of the important sheep breeds in China. Goat milk produced by Hu sheep is characterized with high nutritional value and hypoallergenic in nature. Particularly, this milk contains plenty of milk prebiotic and probiotic bacteria. This study was aimed to scrutinize more bacterial strains from Hu sheep milk with potential probiotic activity.Entities:
Keywords: Antimicrobial activity; Cell surface characteristics; Hu sheep milk; Lactococcus lactis; Leuconostoc lactis; Probiotics
Mesh:
Substances:
Year: 2020 PMID: 32723292 PMCID: PMC7390111 DOI: 10.1186/s12866-020-01920-6
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 4.465
Fig. 1a The evolutionary history was inferred using the Maximum Parsimony method. The bootstrap consensus tree inferred from 500 replicates is taken to represent the evolutionary history of the taxa analyzed. Branches corresponding to partitions reproduced in less than 50% bootstrap replicates are collapsed. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (500 replicates) are shown next to the branches whereas the BLAST alignment results are showed. The abundances of isolated bacterial are shown in the last column. b The microscope micrographs of four LAB strains. c Inhibitory effects of HSM-14 against the pathogen ETEC. The circle wells were filled in different products of HSM-14, including, fermentation broth of cells (pH 3.50) (1 &2) and cell-free supernatant (pH 3.50) without any treatment (3&4), with 15 min heat inactivation (5&6), with pH adjusting from 3.5 to 7.5 using NaOH (7&8), with the treatment of 1 mg/mL trypsin (9&10), and with the treatment of 1 mg/mL protease K (11&12). Some substances (1, 3, 5, 7, 9 and 11) were obtained from the fermentation broth after cultivation under the aerobic condition while others (2, 4, 6, 8, 10 and 12) were from the culture under anaerobic condition
Antimicrobial activity of isolated lactic acid bacteria strains against major foodborne pathogens
| Strain | EHEC | ETEC | A. | |||
|---|---|---|---|---|---|---|
| HSM-1 | 6.1 ± 0.8b | 6.9 ± 1.3a | 7.2 ± 1.8a | 7.2 ± 1.8ab | 6.6 ± 1.0b | 7.4 ± 2.5c |
| HSM-10 | 6.0 ± 0.5b | 7.1 ± 2.0a | 7.9 ± 1.4a | 7.8 ± 2.1ac | 7.7 ± 1.7ac | 10.2 ± 1.9b |
| HSM-14 | 7.1 ± 1.1a | 7.9 ± 1.1a | 7.8 ± 1.2a | 8.2 ± 1.2ac | 7.7 ± 0.9a | 12.5 ± 3.2a |
| HSM-18 | 5.4 ± 0.5b | 5.2 ± 0.6b | 6.5 ± 0.5a | 6.1 ± 1.9b | 6.4 ± 1.1b | 6.2 ± 0.7c |
Note: Data are mean ± SD (n = 3). Mean values with different superscript letters (a–c) in the same row are significantly different, based on LSD test (p < 0.05)
In vitro probiotic properties of isolated lactic acid bacteria strains
| Strain | Auto-aggregation and co-aggregation with pathogens | Hydrophobicity | Heat-treatment | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Auto-aggregation | n-Dodecane | Chloroform | Xylene | 50 °C | 60 °C | 70 °C | ||||
| HSM-1 | 59.9 ± 4.9%a | 52.0 ± 14.9%a | 17.1 ± 6.3%a | 25.2 ± 3.8%ab | 97.8 ± 0.6%a | 82.5 ± 5.5%b | 92.6 ± 1.2%a | 74.6%a | 74.2%a | 0.2%b |
| HSM-10 | 63.5 ± 13.1%a | 35.7 ± 2.3%a | 16.2 ± 4.2%a | 37.6 ± 8.1%ab | 97.9 ± 1.4%a | 84.5 ± 4.0%b | 94.6 ± 1.0%a | 57.5%a | 14.4%b | 0.1%c |
| HSM-14 | 16.5 ± 4.1%b | 51.1 ± 13.1%a | 28.0 ± 3.0%a | 38.1 ± 12.7%a | 97.1 ± 0.7%a | 75.0 ± 7.1%b | 93.4 ± 1.5%a | 32.7%a | 11.6%b | 0.4%ac |
| HSM-18 | 23.7 ± 2.3%b | 52.1 ± 2.9%a | 14.5 ± 4.7%a | 22.7 ± 5.0%b | 86.8 ± 3.8%b | 97.1 ± 0.7%a | 84.8 ± 1.9%b | 9.0%a | 0.0%b | 0.0%a |
Note: Data are mean ± SD (n = 3). Mean values with different superscript letters (a–c) in the same row are significantly different, based on LSD test (p < 0.05)
The sensitivity of probiotic candidates against 30 antibiotics
| Types of Drugs | Drug | μg/pill | HSM-1 | HSM-10 | HSM-14 | HSM-18 |
|---|---|---|---|---|---|---|
| Penicillins | Penicillin | 10 U | 39 (S) | 39(S) | 37(S) | 38(S) |
| Oxacillin | 1 | 27 (S) | 19(I) | 20(I) | 22(S) | |
| Carboxycillin | 100 | 42 (S) | 44(S) | 33(S) | 40(S) | |
| Piperacillin | 100 | 48 (S) | 29(S) | 37(S) | 42(S) | |
| Ampicillin | 100 | 31 (S) | 35(S) | 31(S) | 32(S) | |
| Cephalosporins | Cephalexin | 30 | 33 (S) | 40(S) | 29(S) | 28(S) |
| Cefazolin | 30 | 47 (S) | 25(S) | 27(S) | 45(S) | |
| Cefradine | 30 | 34 (S) | 44(S) | 27(S) | 32(S) | |
| Ceftazidime | 30 | 28 (S) | 44(S) | 17(I) | 29(S) | |
| Cefoperazone | 75 | 41 (S) | 40(S) | 29(S) | 37(S) | |
| Cefatriaxone | 30 | 41 (S) | 38(S) | 26(S) | 35(S) | |
| Cefuroxime | 30 | 48 (S) | 44(S) | 36(S) | 49(S) | |
| Aminoglycosides | Amikacin | 30 | 19 (I) | 19(I) | 11(R) | 24(S) |
| Kanamycin | 30 | 25 (S) | 21(S) | 7(R) | 20(I) | |
| Neomycin | 30 | 22 (S) | 17(I) | 15(R) | 20(I) | |
| Gentamicin | 10 | 22 (S) | 14(R) | 12(R) | 21(S) | |
| Tetracycline | Tetracycline | 30 | 14 (R) | 13(R) | 29(S) | 14(R) |
| Doxycycline | 30 | 22 (S) | 22(S) | 28(S) | 17(I) | |
| Minocycline | 30 | 30 (S) | 27(S) | 35(S) | 26(S) | |
| Macrolides | Erythromycin | 15 | 34 (S) | 29(S) | 28(S) | 32(S) |
| Midecamycin | 30 | 34 (S) | 29(S) | 23(S) | 26(S) | |
| Glycopeptides | Vancomycin | 30 | 31 (S) | 25(S) | 7(R) | 26(S) |
| Quinolones | Norfloxacin | 10 | 18 (I) | 16(I) | 29(S) | 25(S) |
| Ofloxacin | 5 | 32 (S) | 27(S) | 29(S) | 29(S) | |
| Ciprofloxacin | 5 | 27 (S) | 26(S) | 22(S) | 21(S) | |
| Furazolidone | 300 | 23 (S) | 17(I) | 19(I) | 29(S) | |
| Chloramphenicol | 30 | 39 (S) | 36(S) | 36(S) | 36(S) | |
| Clindamycin | 2 | 41 (S) | 37(S) | 27(S) | 40(S) | |
| Sulfonamides | Sulfamethoxazole (SMZ/TMP)△ | 23.75/1.25 | 17 (I) | 18(I) | 8(R) | 20(I) |
| Other classes | Polymyxin | 300 IU | 22 (S) | 5(R) | 7(R) | 24(S) |
Note: The zone of inhibition (diameter in mm) for each antibiotic was measured and expressed as susceptible, S (≥21 mm); intermediate, I (16–20 mm), and resistance, R(<=15 mm)
Fig. 2Microbial population of four LAB strains with a variable pH value and under bile salt conditions at 37 °C. ‘control’ in the figure refers to the experimental results corresponding to the control group (free of HCl, choline and SJC) in each experiment. a Absorsion of the isolates under acidic pH conditions for 24 h at 37 °C in MRS. b Absorsion of the isolates under bile salt conditions for 24 h at 37 °C in MRS. c Transit tolerance in simulated gastrointestinal conditions. Data shown are mean ΔSD of triplicate values of independent experiments